SWTX - SpringWorks Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
772.7M
Enterprise Value 3
53.8M
Trailing P/E
N/A
Forward P/E 1
-11.75
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
-1.41

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 314.45%
52 Week High 328.62
52 Week Low 317.02
50-Day Moving Average 319.71
200-Day Moving Average 320.52

Share Statistics

Avg Vol (3 month) 3238.77k
Avg Vol (10 day) 394.08k
Shares Outstanding 543.23M
Float 349.08k
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Oct 15, 2019) 4919.68k
Short Ratio (Oct 15, 2019) 44.05
Short % of Float (Oct 15, 2019) 44.44%
Short % of Shares Outstanding (Oct 15, 2019) 42.13%
Shares Short (prior month Sep 13, 2019) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -38.14M
Net Income Avi to Common (ttm)-28.75M
Diluted EPS (ttm)-44.68
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)185.29M
Total Cash Per Share (mrq)191.03
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)18.77
Book Value Per Share (mrq)-38.70

Cash Flow Statement

Operating Cash Flow (ttm)-30.49M
Levered Free Cash Flow (ttm)N/A